Misetionamide
- Generic Name
- Misetionamide
- Drug Type
- Small Molecule
- Chemical Formula
- C3H7NO3S
- CAS Number
- 856785-75-6
- Unique Ingredient Identifier
- 489TQ24FC1
Trial to Evaluate Safety and Tolerability of GP-2250 in Combination With Gemcitabine
- First Posted Date
- 2019-02-26
- Last Posted Date
- 2024-02-28
- Lead Sponsor
- Geistlich Pharma AG
- Target Recruit Count
- 64
- Registration Number
- NCT03854110
- Locations
- 🇺🇸
University of Kansas Cancer Center, Fairway, Kansas, United States
🇺🇸Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
🇺🇸Hoag Family Cancer Institute, Newport Beach, California, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath